Effecty Tirzepatide Review: Cost, Brand Access & Honest Verdict (2026)

Effecty: LegitScript certified, with compounded semaglutide starting at $160/month — a genuinely low entry point for a platform that also offers brand-name access alongside its compounded tier. Every fact here comes from the company's own published program.

What Effecty is

Effecty is to be LegitScript certified, offering compounded GLP-1 injections alongside brand-name Ozempic, Wegovy, Zepbound, and Mounjaro — a real dual pathway. It ships nationwide to all 50 states and is part of a broader platform that also covers longevity and women's HRT.

What Effecty costs

Compounded semaglutide starts at $160/month on an annual plan. Compounded tirzepatide runs $240/month, with the full compounded range spanning $160-$205/month depending on medication and plan. Brand-name options are priced at full retail — $1,300-$1,600/month — well above the compounded tier, so weigh that premium carefully if brand access is your priority.

The brand-vs-compounded question

Effecty offers both compounded tirzepatide and a genuine brand-name pathway — a real choice if brand access matters to you, though at a steep premium over compounded. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials; brand tirzepatide is the exact molecule and dose that was. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture, and our Zepbound cost and savings guide for how Effecty's brand pricing compares to other access routes.

How the care model holds up

Effecty's real strengths: LegitScript certification, both compounded and brand-name options on one platform, and no membership fees, transparent pricing, and nationwide shipping. The trade-off: brand-name pricing runs at full retail ($1,300-$1,600/month), and the platform spans a broader catalog — longevity, women's HRT — rather than specializing in weight loss alone. As with any GLP-1 program, compare Effecty's brand pricing against LillyDirect or NovoCare directly before committing to the brand tier; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Effecty's confirmed LegitScript certification and low compounded starting price are genuine positives, and having a real brand-name pathway is a rare option in this category — just know the brand tier runs at full retail. If you specifically want brand access at a lower price, compare LillyDirect's self-pay rate directly in our Zepbound cost and savings guide; for a nationwide compounded-only alternative at a lower entry price, see CoreAge Rx. For a peptide-focused platform this review's live pass couldn't reach, see Elara MD. For another rate-limited provider handled with the same honesty this review applies throughout, see HealthOn. See our best tirzepatide providers ranking for the full field.